14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.470 $0.470 Thursday, 17th Aug 2023 CYAD stock ended at $0.470. During the day the stock fluctuated 0% from a day low at $0.470 to a day high of $0.470.
90 days $0.470 $0.470
52 weeks $0.460 $3.07

Historical Celyad SA prices

Date Open High Low Close Volume
Aug 17, 2023 $0.470 $0.470 $0.470 $0.470 0
Aug 16, 2023 $0.470 $0.470 $0.470 $0.470 0
Aug 15, 2023 $0.470 $0.470 $0.470 $0.470 0
Aug 14, 2023 $0.470 $0.470 $0.470 $0.470 0
Aug 11, 2023 $0.470 $0.470 $0.470 $0.470 0
Aug 10, 2023 $0.470 $0.470 $0.470 $0.470 0
Aug 09, 2023 $0.470 $0.470 $0.470 $0.470 0
Aug 08, 2023 $0.470 $0.470 $0.470 $0.470 0
Aug 07, 2023 $0.470 $0.470 $0.470 $0.470 0
Aug 04, 2023 $0.470 $0.470 $0.470 $0.470 0
Aug 03, 2023 $0.470 $0.470 $0.470 $0.470 0
Aug 02, 2023 $0.470 $0.470 $0.470 $0.470 0
Aug 01, 2023 $0.470 $0.470 $0.470 $0.470 0
Jul 31, 2023 $0.470 $0.470 $0.470 $0.470 0
Jul 28, 2023 $0.470 $0.470 $0.470 $0.470 0
Jul 27, 2023 $0.470 $0.470 $0.470 $0.470 0
Jul 26, 2023 $0.470 $0.470 $0.470 $0.470 0
Jul 25, 2023 $0.470 $0.470 $0.470 $0.470 0
Jul 24, 2023 $0.470 $0.470 $0.470 $0.470 0
Jul 21, 2023 $0.470 $0.470 $0.470 $0.470 0
Jul 20, 2023 $0.470 $0.470 $0.470 $0.470 0
Jul 19, 2023 $0.470 $0.470 $0.470 $0.470 0
Jul 18, 2023 $0.470 $0.470 $0.470 $0.470 0
Jul 17, 2023 $0.470 $0.470 $0.470 $0.470 0
Jul 14, 2023 $0.470 $0.470 $0.470 $0.470 0
Click to get the best stock tips daily for free!

About Celyad SA

Celyad SA Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cancer; CYAD-211, a short hairpin RNA (shRNA)-based allogeneic CAR-T candidate, which is in Phase 1 clinical... CYAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT